Construction of Vector Co-Expressing IL-12 Double Subunits and Its Expression in Human Mesenchymal Stem Cells

高鹏,丁强,方祖军,郑捷

DOI: https://doi.org/10.3969/j.issn.1673-713x.2008.03.008

2008-01-01

Abstract:Objective To construct a vector co-expressing human IL-12 (hIL-12) p40 and p35 subunits and to transfect it into human mesenchymal stem cells (hMSC). Methods Full-length cDNAs of rhIL-12 p40 and p35 subunits was amplified by PCR. The amplified p40 and p35 fragments were used to establish rhIL-12 fusion gene by overlap PCR. The fusion gene was then inserted into the pGEM-T Easy plasmid. Afterwards, identified pGEM-T/rhIL-12 recombinant plasmid was cloned into eukaryotic expression plasmid pcDNA3.1(+) to construct eukaryotic expression vector pcDNA3.1(+)/rhIL-12. And the identified pcDNA3.1(+)/rhIL-12 or pcDNA3.1(+) blank vector (control) was transfected into hMSC mediated by liposome. Inverted microscopy was employed to observe the morphology of hMSC. After the transfection, the expression of rhIL-12 fusion gene in supernatant was detected at day 4 by Western blotting; and the level of the expression was determined by ELISA at days 2, 4, 6, 8, 10, 12, and 14. Results By PCR full-length cDNAs of p40 (1000 bp), p35 (600 bp), and rhIL-12 (1600 bp) were amplified specifically with expected length. The sequence of the cloned rhIL-12 gene was identical to the reported one. Inverted microscopy showed no significant difference in morphology and growth rate between the hMSC transfected with pcDNA3.1(+)/rhIL-12 and the control group. Both Western blotting and ELISA revealed continuous expression of rhIL-12 fusion gene in the supernatant of the hMSC transfected with pcDNA3.1(+)/rhIL-12, while no such expression was detected in the control. Conclusion An eukaryotic vector co-expressing p40 and p35 subunits of hIL-12 has been constructed, such a vector can be used in further studies on non-virus vectors for anti-tumor gene therapy.